Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...